koko体育app

欢迎来到《koko体育app 学报(医学版)》
杨鸣鸣, 范雪娇, 杜文婷, 等. MicroRNA-34a调控细胞衰老的研究[J]. koko体育app 学报(医学版), 2013, 44(1): 1-5.
引用本文: 杨鸣鸣, 范雪娇, 杜文婷, 等. MicroRNA-34a调节作用细胞核变老的的研究[J]. 江西师范大学学报(中医学版), 2013, 44(1): 1-5.
YANG Ming-ming, FAN Xue-jiao, DU Wen-ting, et al. Research on Regulation of Cell Senescence by MiRNA-34a[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 1-5.
Citation: YANG Ming-ming, FAN Xue-jiao, DU Wen-ting, et al. Research on Regulation of Cell Senescence by MiRNA-34a[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 1-5.

MicroRNA-34a调控细胞衰老的研究

Research on Regulation of Cell Senescence by MiRNA-34a

  • 摘要: 目的 探讨微RNA-34a(miRNA-34a)对细胞通过调控沉默交配型信息调节因子2同源蛋白1(SIRT1)的表达,从而引起细胞衰老的作用。 方法 构建pre-miRNA-34a表达载体,并将其和一个不针对任何基因的微小RNA-1792(miRNA-1792)表达载体(其他实验室赠送)分别转染至HEK293和HUVEC细胞内,用RT-PCR、Western blot检测各细胞组SIRT1 mRNA与蛋白表达水平,以未转染的细胞为对照;将HUVEC细胞分为转染不同质粒、未转染质粒和用SIRT1激活剂白藜芦醇(终浓度1 μmol/L,作用2 h)处理HUVEC细胞(HUVEC-Res)组,中性彗星电泳分析H2O2作用2 h 后4组HUVEC细胞的双链损伤情况;用阿霉素处理上述4组HUVEC细胞2 h,β-半乳糖甘酶(SA-β-gal)染色检测各细胞不同时间点的衰老情况。 结果 测序结果表明pre-miRNA-34a表达载体构建成功;RT-PCR、Western blot显示HEK293-pre-miRNA-34a和HUVEC-pre-miRNA-34a中SIRT1 mRNA和蛋白质表达的水平明显下降(P<0.001);中性彗星电泳检测发现经H2O2处理后,HUVEC-Res组DNA损伤最轻,而HUVEC-miRNA-34a组DNA损伤程度最为严重;SA-β-gal染色显示DNA损伤后HUVEC-miRNA-34a衰老程度较其它3组严重,而HUVEC-Res组的衰老程度最为轻微。 结论 miRNA-34a 通过抑制SIRT1表达调控细胞衰老。  
    Abstract: Objective To determine miRNA-34a regulated cell senescence indirectly through targeting silent mating-type information regulation 2 homologue 1 (SIRT1) in vitro experiment. Methods A constructed pre-miRNA -34a expression vector and a miRNA-1792 expression vector (not directly against any gene) were transfected into HEK293 and HUVEC cell lines respectively. The expression levels of SIRT1 in each cell groups were detected by RT-PCR and Western blot. The HUVEC cells were divided into different group:transfected with pre-miRNA-34a expression vector (HUVEC-pre-miRNA-34a), transfected with miRNA-1792 expression vector (HUVEC-pre-miRNA-1792), treated HUVEC cell with SIRT1 activator resveratrol (final concentration 1 μmol/L, treatment for 2 h)(HUVEC-Res), and HUVEC cells without any treatment as the control. Comet assay was applied to detect the oxidative damage of above-mentioned cells after H2O2 treatment for 2 h, and beta-galactosidase (SA-β-gal) staining was used to detect the senescence of them in different time points after doxorubicin treatment for 2 h. Results Pre-miRNA-34a expression vector was constructed successfully by sequencing confirmation. RT-PCR and Western blot indicated that the overexpression of miRNA-34a down regulated mRNA and protein level of SIRT1 in HEK293-miRNA-34a and HUVEC-miRNA-34a cell groups (P<0.001). Comet assay revealed that HUVEC-miRNA-34a cell group was the most sensitive to H2O2 treatment, and the DNA damage of HUVEC-Res cell group was the most minor. HUVEC-miRNA-34a cell group displayed higher frequency of SA-β-gal staining than that of other cell groups. Conclusion miRNA-34a regulated cell senescence indirectly through targeting SIRT1.  
© 2013 《koko体育app 学报(医学版)》编辑部 版权所有 cc

开放获取🥃 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问

/

返回文章
返回
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); koko体育-koko体育app koko体育-koko体育网页版koko体育app koko体育-全站app下载(官网) m6米乐app|下载 m6米乐app|主頁欢迎您!!